Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
1406
result was found. Results that relate to
R
Retrospective study of effect of inhaled corticosteroids on prognosis of chronic obstructive pulmonary disease associated with community-acquired pneumonia
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):279-285.
1591 times
534 times
Zhi-Bo CHEN
Ning-Ning YU
Sheng-Le LIN
Chronic obstructive pulmonary disease
Community-acquired pneumonia
Inhaled corticosteroids
Prognosis
Details
The effects of butylphthalide soft capsule on the expression of uric acid and the pathological changes of white matter in patients with moderate and severe leukoaraiosis
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):286-292.
1666 times
617 times
Lin LI
Hai-Yang XIE
Yan-Kun QIN
Butylphthalide soft capsule
Moderate and severe leukoaraiosis
Plasma uric acid
Leukoaraiosis
Cognitive function
Details
The impact of empirical antibiotic treatment on the prognosis of patients with acute calculous cholecystitis
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):293-297.
1688 times
541 times
Wei-Wei KOU
Chao-Yang HUI
Guang-Ming REN
Zhang-Feng DANG
Cholecystitis
Acute calculous cholecystitis
Experience in antibiotic treatment
Complications
Details
The effects of sacubitril-valsartan tablets on the expressions of NT-proBNP, cTnI and cardiac function in patients with chronic cardiac insufficiency
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):298-303.
1611 times
561 times
Qiu-Shi WANG
Xiao-Ran LI
Yao YAO
Sacubitril-valsartan tablets
Chronic cardiac insufficiency
N terminal pro B type natriuretic peptide
Troponin I
Cardiac function
Details
Analysis of medicinal value of gold based on ancient and modern comparison
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):304-310.
3246 times
1324 times
Shuo CHEN
Nan WANG
Lian-Sheng YANG
Wei-Zhe DENG
Zhi-Xin YANG
Gold
Gold preparation
Gold nanoparticles
Image comparison class
Details
The clinical value of UPLC-MS/MS method for the determination of plasma and tissue isoniazid concentration in lymph node tuberculosis patients
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):311-318.
1618 times
583 times
Yu ZHANG
Xiao-Yu LIU
Feng XU
Huan ZHANG
Qiao-Yan DING
Li-Hua MA
Si-Si LI
Ming ZHOU
Lymph node tuberculosis
Isoniazid
Ultra performance liquid chromatography-mass spectrum/mass spectrum
Details
Multi-component comprehensive quality evaluation of Tongjing ointment
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):319-331.
1666 times
668 times
Ling-Chao RAN
Jin-Ying FENG
Zhi-Ming LI
Kang-Kang JI
Tongjing ointment
High performance liquid chromatography-quantitative analysis of multi-components by a single marker
Chemometrics
Grey relational analysis
Comprehensive evaluation
Details
Improvement of quality standard of Xiaojin capsules
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):332-338.
1726 times
567 times
Shuang LIU
Mao-Quan LIN
Jing JIN
Zhi-Jun HUANG
Yang XIANG
Gang ZHAO
Kai-Li MING
Xiaojin capsules
Quality standard
Acetyl-11-keto-β-boswellic acid
High performance liquid chromatography
Gas chromatography fingerprint
Details
Establishment of a discrinatory dissolution method for orlistat capule and evalution of the similarity of dissolution curue
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):339-345.
1853 times
545 times
Wan WANG
Qi LI
Yan-Ming LIU
Yi LIU
Chang-Liang LI
Orlistat capsules
High performance liquid chromatography
Dissolution curve
Dissolution curve similarity factor
Consistency evaluation
Details
Effects of Anemarrhenae Rhizoma on the dissolution of 6 inorganic elements in Gypsum Fibrosum under different compatibility ratio based on grey correlation analysis and TOPSIS model
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):346-354.
1728 times
660 times
Xiao-Dong YANG
Guo-Wei LI
Wen-Ping WU
Xiao-Lin LIU
Xiang-Dong CHEN
Ju-Lin XING
Wei PANG
Li-Ye PAN
Gypsum Fibrosum
Anemarrhenae
R
hizoma
Inductively coupled plasma mass spectrometry
Grey correlation analysis
Technique for order preference by similarity to an ideal solution
Details
Determination of illegally added metolazone in tablet candy by Captiva EMR-Lipid technology combined with UPLC-Q-TOF/MS
Published on
Frontiers in Pharmaceutical Sciences
2023,36(11):355-360.
2311 times
660 times
Hua WANG
Chan CHEN
Hong-Hong LIU
Shan-Shan HE
Da-Long LUO
Metolazone
Captiva EM
R
-Lipid solid phase extraction
Quadrupole time of flight mass spectrometry
Tablet candy
Illegally added drugs
Details
Construction and validation of a prognostic risk model for patients with acute myeloid leukemia based on bioinformatics
Published on
Journal of Mathematical Medicine
2023,36(12):888-898.
2291 times
796 times
Si-Na ZHANG
Shu-Jie MA
Acute myeloid leukemia
Bioinformatics
The Cancer Genome Atlas
Genotype-Tissue Expression
Prognostic model
R
andom forest
Details
Effect of platinum-containing regimen combined with chemotherapy on the survival of elderly patients with advanced non-small cell lung cancer
Published on
Journal of Mathematical Medicine
2023,36(12):899-905.
1830 times
740 times
Xue-Xing WANG
Yuan HE
Jie CHU
Yu-Feng WANG
Non-small cell lung cancer
R
etrospective cohort study
Chemotherapy
The elderly
Survival analysis
Details
Biapenem combined with levofloxacin in the treatment of severe pneumonia caused by MDR-PA: a Meta-analysis
Published on
Journal of Mathematical Medicine
2023,36(12):906-916.
1892 times
715 times
Wei LIN
Jie ZHANG
Song QING
Fang-Min ZHAO
Biapenem
Levofloxacin
Multi-drug resistant pseudomonas aeruginosa
Pneumonia
Meta-analysis
Details
Research progress of leukemia inhibitory factor in tumors
Published on
Journal of Mathematical Medicine
2023,36(12):917-924.
2317 times
727 times
Sheng-Zhao LI
Ze-Ying LAI
Qing-Shui WANG
Leukemia inhibitory factor
Tumor
Signal pathways
Treatment
Details
上一页
1
2
37
38
39
40
41
42
43
93
94
下一页